Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Hydralazine 20mg powder for solution for injection ampoules |
BNF code | 0205010J0AAAKAK |
Virtual Therapeutic Moiety | Hydralazine |
Date identifier became valid | 13 Mar 2017 |
Previous product identifier | 318651004 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Date of name applicability | 26 May 2004 |
Previous name | Hydralazine 20mg injection ampoules |
Basis of previous name | rINN - Recommended International Non-proprietary |
Reason for name change | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | ampoule |
Unit dose unit of measure | ampoule |
Virtual Product Ingredient | |
---|---|
Ingredient | Hydralazine hydrochloride |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 20.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | solutioninfusion.intravenous |
Ontology Drug Form & Route | |
Form & Route | solutioninjection.intravenous |
Dose Form | |
Formulation | Powder for solution for injection |
Drug Route | |
Route | Intravenous |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Hydralazine 20mg powder for concentrate for solution for injection ampoules (Advanz Pharma) | |
Virtual Medicinal Product Packs | |
Hydralazine 20mg powder for solution for injection ampoules 5 ampoule |
dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.